Figure 1From: Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: A parallel, randomized, double blind studyAverage EPO concentration in serum. Data correspond to patients who received 100 IU/Kg of Heberitro (solid line) or Eprex (dashed line) at time 0. Standard deviations are not shown for the sake of simplicity of the illustration. Curves were not significantly different at any point in a multiple determinations ANOVA with Bonferrony's correction.Back to article page